Journal Club: Analyzing the Latest Research 📚

Created using ChatSlide

Explore the groundbreaking research on semaglutide's potential in managing Major Depressive Disorder (MDD) with a focus on cognitive improvement and safety. This 16-week double-blind trial evaluated the efficacy of semaglutide compared to placebo in participants with MDD, highlighting improvements in global cognition and weight, though not in executive function. The study, funded by Physicians' Services Incorporated and executed by a collaborative authorship, underscores the promise of...